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Introduction
Podocytes play a key role in the regulation of glomerular 
permeability to albumin and maintain spatial structure of 
glomerulus by withstanding high intraglomerular hydro-
static pressure, mainly through a well-developed contrac-
tile apparatus formed by actin and myosin filament bun-
dles [1]. These terminally differentiated epithelial cells are 
situated on the urinary side of glomerular capillaries and 
together with the glomerular basement membrane (GBM) 
and endothelial cells form renal filtration barrier. They are 
anchored to the GBM through their foot processes, and 
adjacent foot processes interdigitate, creating a narrow 
space (30–50  nm) with a complex set of membrane pro-
teins, called glomerular slit diaphragm [2]. Within the renal 
filtration barrier podocytes are the cells that are uniquely 
insulin-sensitive and capable of increasing extracellular 
glucose uptake in response to insulin stimulation by facili-
tating glucose transporter translocation to cell membranes 
[3]. Altered morphology and reduced number of podocytes 
are the earliest pathological manifestations associated with 
diabetic nephropathy (DN), a leading cause of renal failure 
requiring renal replacement therapy in diabetic patients [4, 
5]. Progressive development of insulin resistance observed 
at the early stage of type 2 diabetes causes an increase in 
blood glucose concentration (hyperglycemia) and compen-
satory rise of insulin levels [5]. Insulin resistance is charac-
terized by a suppressed insulin-stimulated glucose uptake 
by the cells, resulting from the impairment of intracellular 
insulin signaling pathways and disability to increase the 
amount of glucose transporters (GLUTs) in the cell mem-
brane [6]. Defective insulin responsiveness occurs as a con-
sequence of genetic susceptibility and effects of extracel-
lular agents [7], among which the excess of free fatty acids, 
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chronic hyperglycemia and hyperinsulinemia are currently 
of particular research interest [8, 9].
Long-term hyperglycemia causes impairment of podo-
cytes morphology and function, including foot processes 
effacement, hypertrophy, detachment from the GBM, and 
apoptosis, thus leading to the increased permeability of the 
filtration barrier to albumin and progressive decline of renal 
function [10]. Podocytes have very limited ability for cell 
division, therefore, their loss, although initially balanced by 
hypertrophy of the remaining podocytes, cannot be com-
pensated by proliferation or efficient recruitment and dif-
ferentiation of other glomerular cells [11, 12]. To endure 
adverse environmental changes, podocytes activate their 
intracellular defense mechanisms, among which autophagy 
is thought to be the most important one [13].
Autophagy serves as an adaptive mechanism aimed 
to remove improperly folded proteins and non-functional 
intracellular organelles, which might be produced during 
enhanced protein synthesis observed in cellular hyper-
trophy. Autophagic process involves a series of following 
steps including initiation, cargo recognition, autophago-
some formation, autophagosome-lysosome fusion, diges-
tion, and release of digested products into the cyto-
plasm. The process is initiated by Unc-51-like kinase-1/2 
(ULK1/2) complex, under control of AMP-activated and 
the mammalian target of rapamycin (mTOR) kinases [14]. 
The membrane of the autophagosome is doubled in elonga-
tion process and its closure is regulated by Beclin1/PI3K 
class III complex, together with two conjugating systems 
involving LC3 protein processing and Atg12-Atg5-Atg16 
complex [15]. Activity of autophagy is closely related to 
intracellular energy state, and all its signaling pathways are 
tightly regulated. Starvation, increased reactive oxygen spe-
cies generation, or mechanical stress are the strong induc-
ers of autophagy, aimed to maintain intracellular homeosta-
sis in harsh conditions [16, 17].
Although the pathogenesis of DN remains to be fully 
elucidated, autophagy is currently considered as one of the 
key factors contributing to the disease [18–20]. Impaired 
autophagic activity in podocytes was observed in diabetic 
patients with proteinuria but not in those with no or mini-
mal proteinuria [19]. It was also demonstrated on mice that 
podocyte-specific Atg5 deletion and high-fat diet lead to 
albuminuria, activation of apoptosis in podocytes and their 
loss [19]. Moreover, inhibition of podocytes autophagy in 
mice (Atg5 knockout) resulted in albuminuria by 2 months 
of age, renal segmental lesions with hyalinosis, and tuft-to-
capsule adhesions by 4 months of age [21], indicating that 
proper podocyte autophagy is critical for normal kidney 
function. Additionally, recently published studies suggest 
that autophagy may be directly linked to the development 
of podocyte insulin resistance [22] and may constitute a 
protective mechanism against high glucose-dependent 
development of insulin resistance in these cells [23]; there-
fore, it is of interest to further investigate the significance 
of autophagy for viability and insulin responsiveness of pri-




Cell culture reagents were purchased from Sigma-Aldrich 
(St. Louis, MO, USA), with the exception of fetal bovine 
serum (FBS), which was purchased from Gibco, Invitro-
gen (Carlsbad, CA, USA). Rabbit polyclonal antibodies 
against LC3 and mouse monoclonal antibody against actin 
were obtained from Sigma-Aldrich. Alkaline phosphatase-
conjugated secondary antibodies (goat anti-rabbit and don-
key anti-mouse antibodies) were obtained from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Small interfering 
RNA (siRNA) targeting Atg5 and its non-silencing con-
trol siRNA were obtained from OriGene (Rockville, MD, 
USA). Plasmid ptfLC3 was purchased from Addgene (plas-
mid 21,074). [1,2-3H]-deoxy-d-glucose was obtained from 
MP Biochemicals (Santa Ana, CA, USA). All other rea-
gents were purchased from Sigma-Aldrich.
Primary podocyte culture
All rats were maintained and studied in accordance with 
the protocol reviewed and approved by the local Bioethi-
cal Committee at the Medical University of Gdansk (No. 
4/2012). Primary rat podocytes were obtained from Wistar 
female rats weighing 100–120  g as described previously 
[24]. Cell phenotypes were determined using podocyte-
specific antibodies against Wilms’ tumor-1 protein (WT-1; 
Biotrend Koeln, Germany) and synaptopodin (Progen, Hei-
delberg, Germany). Depending on the experiment, podo-
cytes were incubated in high glucose medium (HG; 30 mM 
d-glucose), osmotic control medium (Osm con; 11  mM 
d-glucose with 19  mM l-glucose), or standard glucose 
medium (SG; 11 mM d-glucose).
Western blot analysis
Podocytes were washed with ice-cold PBS and homog-
enized in an ice-cold lysis buffer. The lysates were then 
centrifuged for 20  min at 15,000×g. Equal amounts of 
protein extracts (20  μg per well) were resolved by SDS-
PAGE, transferred onto a PVDF membrane, and blocked 
with 3% fat-free milk in TBS (20 mM Tris-HCl, 140 mM 
NaCl). Next, the membrane was incubated overnight with 
primary antibodies against LC3 (1:500) and actin (1:3000). 
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Following incubation with the appropriate secondary alka-
line phosphatase-conjugated antibodies (1:5000), protein 
bands were detected using the colorimetric 5-bromo-4-
chloro-3-indolyl phosphate/nitroblue tetrazolium (BCIP/
NBT) system. Densitometric quantification of bands was 
performed with Quantity One software (Bio-Rad, Hercules, 
CA, USA).
Nucleofection with plasmid DNA
Podocytes seeded on type I collagen-coated 24-well plates 
(Greiner Bio-One, Austria) at 70–80% confluency were 
transfected with an Amaxa AD1 Primary Cell 4D-Nucle-
ofector-Y Kit (Lonza, Switzerland) and ptfLC3 plas-
mid (16  µg per well) using the FB-166 program on the 
4D-Nucleofector System (Lonza). Immediately after nucle-
ofection, cells were transferred into 1  ml of pre-warmed 
RPMI 1640 medium.
Cell were incubated in indicated media, and every 24-h 
15–30, images were taken using an Olympus IX51 fluores-
cence microscope (Olympus, Japan). Total fluorescence 
signal was measured for autophagosomes and autolys-
osomes using CellSens Dimension software (Olympus, 
Japan). The results were presented as autolysosome to 
autophagosome fluorescence ratios.
siRNA transfection
Podocytes were cultured in type I collagen-coated culture 
flasks in RPMI 1640 with 10% FBS and then transfected 
with siRNA Transfection Reagent (Santa Cruz Biotech-
nology) following the manufacturer’s instructions. Non-
specific (scrambled) siRNA and Atg5 siRNA were diluted 
in Transfection Medium to a final concentration of 50 nM. 
Cells were cultured for 24  h and then incubated in SG, 
HG, or Osm con medium for 5 days. Parallel to monitor-
ing autophagic vacuoles formation in Atg5 siRNA trans-
fected viable podocytes, nucleofection using ptfLC3 was 
performed.
MTT test
Podocytes were seeded at 3 × 104/well on a type I colla-
gen-coated 24-well plate, and cultured under control and 
experimental conditions. MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) was added to each 
well to a final concentration of 0.2 mg/ml. Next cells were 
incubated at 37 °C for 4 h, medium was removed, and the 
intracellular formazan was solubilized in 300  μl DMSO. 
Absorbance was measured at 560  nm with a reference of 
690 nm using a  VICTOR3 Multilabel Counter 1420 (Perkin 
Elmer, Waltham, USA).
[1,2-3H]-deoxy-d-glucose (2-DG) uptake measurements
Podocytes were cultured on a type I collagen-coated 
24-well plate under control (SG) and experimental (SG 
supplemented with 300 nM insulin) conditions. On the day 
of experiment, cells were starved for 2 h in FBS- and glu-
cose-free medium. Next [1,2-3H]-deoxy-d-glucose (2-DG) 
was added to a final concentration of 1 μCi/well and podo-
cytes were incubated in 37 °C, 5%  CO2 for 3 min. 400 μl of 
medium from each well was suspended in 2 ml of scintilla-
tor cocktail for extracellular radioactivity measurements by 
liquid scintillation counting  (MicroBeta2®, Perkin Elmer, 
Waltham, USA). Remaining medium was removed, podo-
cytes were washed three times with ice-cold PBS and lysed 
in 0.05 N NaOH for 1.5 h at room temperature. The lysates 
(400 μl/well) were transferred to scintillator cocktail (2 ml) 
and intracellular radioactivity was measured  (MicroBeta2®, 
Perkin Elmer, Waltham, USA). The remaining lysates 
(100 μl) were used to determine the protein concentration 
using Bradford method [25].
Statistics
All data are expressed as mean ± SEM. Quantitative com-
parisons were performed using ANOVA followed by the 
Student–Newman–Keuls multiple comparison test. A P 
value of <0.05 was considered significant.
Results
Autophagy is involved in extracellular high glucose 
concentration-dependent decrease in primary rat 
podocyte viability
In order to determine the viability of primary rat podo-
cytes cultured in HG medium, MTT test was conducted. 
After 5  days of incubation in HG, we observed a reduc-
tion of metabolically active podocytes of about 22% in HG 
medium (30 mM d-glucose) when compared to SG medium 
(11 mM d-glucose) (P < 0.05), while in podocytes cultured 
for 5 days in SG and subsequent staurosporine stimulation 
(0.5 μM, 3 h; positive control), there was 30% decrease in 
cell viability (P < 0.05) (Fig. 1a).
Next, we investigated whether autophagy is involved in 
the reduced podocyte viability in HG. Incubation of Atg5-
depleted podocytes in HG medium for 5  days led to the 
decline in cell viability of about 42% (P < 0.05) when com-
pared to podocytes maintained in SG medium (Fig.  1b). 
Podocytes transfected with non-targeting siRNA (negative 
control) and cultured in HG for 5 days had abolished cell 
viability by 24% (P < 0.05) (Fig. 1b). To exclude the effect 
of elevated osmotic pressure in HG medium on podocytes, 
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we assessed podocyte viability in non-transfected and 
transfected cells cultured for 5  days in high osmolarity 
(11 mM d-glucose with 19 mM l-glucose; Osm con) and 
SG medium (Fig.  1a, b). Autophagy downregulation in 
podocytes resulted in approximately 2,5-fold decrease in 
autolysosome/autophagosome ratio 5  days after the trans-
fection (Fig.  1c).Transfection conditions did not affect 
podocytes viability (Fig.  1d). Podocyte transfection with 
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Atg5 siRNA resulted in the decrease of Atg5–Atg12 com-
plex formation by 30% (Fig. 1e).
High glucose impairs activity of autophagy in primary 
rat podocytes
Autophagy flux was analyzed in primary rat podocytes 
transfected by nucleofection with ptfLC3 plasmid express-
ing RFP-GFP-LC3 construct, which enables tracing 
autophagosome and autolysosome formation in viable cells 
within the course of time. After 5 days of podocyte incu-
bation in HG medium, we observed significant decrease in 
LC3-II protein expression of about 32% when compared to 
SG medium (0.37 ± 0.04 vs. 0.25 ± 0.05, P < 0.05) (Fig. 2a, 
b). The LC3-I level was unchanged in podocytes cultured 
in both SG and HG (Fig. 2a, b). Reduced number of autol-
ysosomes (red dots) toward autophagosomes (yellow/green 
dots) was observed in the fluorescence images of podocytes 
cultured for 5 days in HG medium (Fig. 2c), what was con-
firmed in the autophagy flux analyses (Fig. 2d).
Downregulation of autophagy alleviates podocyte 
responsiveness to insulin
In order to determine if autophagy plays an important role 
in podocyte sensitivity to insulin, we transfected podo-
cytes with Atg5 siRNA or non-specific control siRNA 
and analyzed time-dependent effects of insulin (300  nM) 
on intracellular [1,2-3H]-deoxy-d-glucose (2-DG) uptake. 
The uptake of 2-DG in podocytes transfected with con-
trol siRNA was increased by 35% after 60  min of insu-
lin stimulation (5.38 ± 0.64  nmol/min/mg protein vs. 
7.27 ± 1.23  nmol/min/mg protein, P < 0.05) (Fig.  3a), 
whereas 3 as well as 5  days of stimulation with insulin 
abolished this effect (control: 5.38 ± 0.64  nmol/min/mg 
protein; 3-days insulin incubation: 5.4 ± 1.03 nmol/min/mg; 
5-days insulin incubation: 4.52 ± 0.98  nmol/min/mg pro-
tein) (Fig.  3a). However, in Atg5-depleted podocytes, we 
did not observe any effect of insulin on intracellular 2-DG 
transport at any of the time points (Fig. 3a).
To determine the involvement of Atg5 in sensitivity 
of primary rat podocytes to insulin, we analyzed insulin-
dependent uptake of 2-DG into the podocytes transfected 
with Atg5 siRNA or non-targeting siRNA after subsequent 
incubation in SG, HG, and Osm con media for 5 days. In 
podocytes transfected with non-specific siRNA and cul-
tured in SG or Osm con, short stimulation with insulin 
(300  nM, 3  min) resulted in significantly increased 2-DG 
transport into the cells by about 28 and 29%, respectively 
(2.34 ± 0.22  nmol/min/mg protein vs. 2.99 ± 0.15  nmol/
min/mg protein (SG) and 2.47 ± 0.23 nmol/min/mg protein 
vs. 3.2 ± 0.26  nmol/min/mg protein (Osm con), P < 0.05), 
while there was no effect of insulin on 2-DG uptake into 
podocytes cultured for 5 days in HG medium (Fig.  3b). 
Similar effect was observed in podocytes with downregu-
lated autophagy, where stimulation with insulin (300 nM, 
3 min) caused significant increase in 2-DG transport after 
incubation in SG medium (Δ32%, P < 0.05) or Osm con 
medium (Δ37%, P < 0.05) for 5 days, whereas there was no 
effect of insulin on 2-DG uptake in podocytes cultures in 
HG medium (Fig. 3c).
Discussion
Autophagy constitutes one of the most important defense 
mechanisms involved in maintaining podocytes intracellu-
lar homeostasis by removing misfolded proteins and non-
functional organelles [20, 26]. Basal activity of podocytes 
autophagy, the highest among all the kidney cells [13], is 
associated with high metabolic activity of these non-divid-
ing cells to sustain permanent filtration of large volume of 
serum (600  ml/min in human) and low-molecular-weight 
proteins, including albumin (up to several g/day), and 
result in the necessity of constant intracellular proteomic 
turnover. DN is characterized by the impairment of renal 
filtration mainly due to alterations in podocyte morphol-
ogy and function, therefore multiple studies have been try-
ing to elucidate the potential effects of diabetic milieu on 
podocyte physiology. Previously published reports do not 
provide unequivocal answer whether autophagy is acti-
vated or inhibited in high glucose environment (HG). It has 
been shown that number of autophagosomes in podocytes 
in diabetic rats is increased. Moreover, increased LC3 and 
beclin1 expression was shown in immortalized mice podo-
cytes cultured in HG [27]. In contrary, it has also been 
shown that both markers of autophagy as well as number 
of autophagic vacuoles were decreased in different mod-
els of experimental diabetes [28]. Recent study has shown 
a decrease in the LC3-II expression and in the number of 
autophagic vesicles in podocytes of diabetic patients and 
Fig. 1  Effects of autophagy downregulation on primary rat podocyte 
viability (MTT test). Podocytes were cultured in high d-glucose (HG; 
30  mM), standard d-glucose (SG; 11  mM), or in 11  mM d-glucose 
with 19 mM l-glucose (Osm con; osmotic control) for 5 days. a Via-
bility of intact podocytes cultured in SG, HG and Osm con media for 
5  days. The positive control was treated with staurosporine (Staur; 
0.5 µM; 3 h). Values are means ± SEM (n = 3). *P < 0.05 versus SG. 
b Podocytes were transfected with Atg5 siRNA or scrambled siRNA 
and cultured in indicated media for 5 days. Values are means ± SEM 
(n = 3). *P < 0.05 versus SG scrambled siRNA, **P < 0.05 versus 
SG Atg5 siRNA, ***P < 0.05 scrambled siRNA versus Atg5 siRNA. 
c Intracellular autolysosomes to autophagosomes ratio after Atg5 
siRNA transfection. Values are means ± SEM (n = 8–20). *P < 0.05 
versus Control. d Atg5 siRNA and scrambled siRNA transfection 
effect on podocyte survival in standard medium (SG; 5 days). e Rep-
resentative immunoblots for Atg5–Atg12 complexes in podocyte after 
transfection with siRNA for Atg5
◂
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Fig. 2  Effect of high glucose on LC3 expression in primary rat 
podocytes. Podocytes were cultured in high d-glucose (HG; 30 mM), 
standard d-glucose (SG; 11 mM), or 11 mM d-glucose with 19 mM 
l-glucose (Osm con; osmotic control) for 5 days. a Quantitative den-
sitometric analysis was used to determine the ratios of LC3-I to actin 
and LC3-II to actin. Values are means ± SEM (n = 12). *P < 0.05 ver-
sus SG LC3-II/actin. b Representative immunoblot. c Representative 
images of intracellular localization of GFP-RFP-LC3 protein in podo-
cytes after nucleofection and incubation in the indicated media for 
5 days. d Autophagy flux analyses in podocytes after GFP-RFP-LC3 
nucleofection. Total fluorescence for red (RFP; autolysosomes) and 
yellow (GFP and RFP; autophagosomes) emission signals was deter-
mined in each image. Values are means ± SEM (n = 10–20 images for 
each cell culture). (Color figure online)
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rodents. Moreover, decreased podocyte viability has been 
observed in HG [19]. In our work, we have shown that 
long-term exposure of primary rat podocytes to high glu-
cose indeed promotes podocyte death, and attenuation of 
autophagy further deteriorates this process. Experimental 
conditions, which were used to inhibit podocyte autophagy, 
did not affect cell viability in control environment, there-
fore indicating that podocytes are capable to compensate 
mild disturbances in autophagy activity, however, not 
under long-term exposure to unfavorable milieu. Addi-
tionally, we observed a reduced expression of LC3-II and 
a decreased number of intracellular autophagic vacuoles in 
podocytes cultured for 5 days in HG, when compared with 
both standard medium and osmotic control. Thus, there was 
no effect of the osmotic pressure on the autophagy activ-
ity in cells cultured in HG. In our previous work, we have 
shown that podocytes cultured for 5 days in HG failed to 
increase d-glucose uptake in response to insulin treatment 
[29]. Moreover, variety of cell types has been reported to 
develop insulin resistance following the long-term insulin 
treatment [9, 30, 31]. In the current work, we have shown 
for the first time that mild inhibition of autophagy activity 
Fig. 3  Involvement of autophagy in the development of insulin 
resistance in primary rat podocytes. a Measurements of [1,2-3H]-
deoxy-d-glucose (2-DG) intracellular transport in podocytes trans-
fected with Atg5 siRNA or scrambled siRNA and treated with insulin 
(300 nM) for the indicated times. Values are means ± SEM (n = 4–8). 
*P < 0.05 versus Control scrambled siRNA. b Measurements of insu-
lin-dependent 2-DG uptake in podocytes transfected with scrambled 
siRNA and incubated in standard d-glucose (SG; 11 mM), high d-glu-
cose (HG; 30 mM), or with 11 mM d-glucose with 19 mM l-glucose 
(Osm con; osmotic control) for 5 days. Insulin stimulation (300 nM) 
was performed during 3  min. Values are means ± SEM (n = 5). 
*P < 0.05 versus SG Control, **P < 0.05 versus Osm con Control. c 
Measurements of insulin-dependent 2-DG uptake in podocytes trans-
fected with Atg5 siRNA and incubated in SG, HG, or Osm con for 
5 days. Insulin stimulation (300 nM) was performed for 3 min. Values 
are means ± SEM (n = 7). *P < 0.05 versus SG Control, **P < 0.05 
versus Osm con Control
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is sufficient to impair responsiveness of podocytes to insu-
lin that was observed in cells transfected with Atg5 siRNA. 
2-DG uptake was unchanged after 60 min of insulin treat-
ment, whereas in control podocytes, intracellular 2-DG 
transport was increased by 35%. After long-term incuba-
tion with insulin (3 and 5 days), there was no effect of insu-
lin on 2-DG uptake in podocytes transfected with Atg5 or 
scrambled siRNA, what may indicate the development of 
insulin resistance in podocytes. These results are in agree-
ment with recently published work of Xu et  al., where 
the authors observed decreased autophagy in immortal-
ized human podocytes after knocking down the insulin 
receptor, suggesting that proper insulin signaling is criti-
cal for autophagy in podocytes [22]. We have also shown 
direct influence of insulin on the expression of markers of 
autophagy in podocytes, as well as on their permeability 
to albumin [24]. In our present study, we have also investi-
gated if downregulation of autophagy has any effect on the 
2-DG uptake in podocytes cultured in HG. Here, in both 
transfected with Atg5 or scrambled siRNA cell cultures, 
we observed abolished effect of HG on insulin-depend-
ent intracellular 2-DG transport, indicating that preced-
ing downregulation of Atg5 signaling, which may impair 
autophagy activity, does not influence insulin resistance 
development after long-term HG treatment. However, it 
should be noted that high percentage of podocytes dying 
in HG may also indicate a progressive deterioration of 
remaining cell function and viability, which might involve 
a dysregulation of various intracellular pathways, including 
insulin signaling pathway. Therefore, this aspect can be a 
promising field for further investigation.
Taking under account all studies conducted so far, it 
seems possible, that downregulation of autophagy, that 
is observed in podocytes exposed to hyperglycemic envi-
ronment, can represent the effect of reduced sensitivity of 
podocytes to insulin elicited by long-term exposure to HG, 
and may also contribute to the decreased viability of these 
cells.
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